I don't think we should be leveling blame at anyone as we don't really know the inner workings of the company and the whole business model, as well as the obstacles to get sales. Sure, having Sozo recommended in the NCCN guidelines for lymphedema helps but to actually see sales increase could take some time under any management.
I don't think we should be leveling blame at anyone as we don't...
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $161.8M | |||
| Open | High | Low | Value | Volume |
| 8.1¢ | 8.2¢ | 8.0¢ | $104.8K | 1.309M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 166577 | 8.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.1¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.1¢ |
Change
0.000 ( 1.25 %) |
||||
| Open | High | Low | Volume | ||
| 8.0¢ | 8.1¢ | 8.0¢ | 135749 | ||
| Last updated 12.21pm 03/05/2024 ? | |||||
| IPD (ASX) Chart |